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ABSTRACT: Several studies suggest that one possible cause of impaired wound healing is failed or insufficient
lymphangiogenesis, that is the formation of new lymphatic capillaries. Although many mathematical models have
been developed to describe the formation of blood capillaries (angiogenesis), very few have been proposed for the
regeneration of the lymphatic network. Lymphangiogenesis is a markedly different process from angiogenesis,
occurring at different times and in response to different chemical stimuli. Two main hypotheses have been
proposed: 1) lymphatic capillaries sprout from existing interrupted ones at the edge of the wound in analogy
to the blood angiogenesis case; 2) lymphatic endothelial cells first pool in the wound region following the lymph
flow and then, once sufficiently populated, start to form a network. Here we present two PDE models describing
lymphangiogenesis according to these two different hypotheses. Further, we include the effect of advection due
to interstitial flow and lymph flow coming from open capillaries. The variables represent different cell densities
and growth factor concentrations, and where possible the parameters are estimated from biological data. The
models are then solved numerically and the results are compared with the available biological literature.
1 Introduction
The lymphatic system first came to the anatomists’ attention with Hippocrates’ mention of lymph nodes in his
5th century BC work On Joints [112]. Later, the Roman physician Rufus of Ephesus identified the axillary,
inguinal and mesenteric nodes and the thymus in the 1st-2nd century AD [67]. The earliest reference to lymphatic
vessels is attributed to the anatomist Herophilus, who lived in Alexandria in the 3rd century BC; he described
the lymphatics as “absorptive veins” [22, 105]. This rudimentary knowledge of the lymphatic system was lost
during the Middle Ages, until Gabriele Falloppio re-discovered lymphatic capillaries in the mid-16th century [16].
Since then, there has been a steady but slow increase in our awareness of the “second” circulatory system of our
body (see [2] for an account of immunology’s priority disputes in the 17th and 18th centuries). Major impetus
to study the lymphatic system came only in the 1990s, after the discovery of a suitable lymphatic marker that
allowed quantifiable observation of lymphatic dynamics [18, 77]. Lymphatic research is still a current trend in
biomedicine and a source of sensational new discoveries, such as the 2015 finding of lymphatic vessels in the
central nervous system [58].
An impetus for studying lymphatic regeneration is provided by recent biological studies that propose lym-
phangiogenesis as a major target for the treatment of non-healing wounds: functional lymphangiogenesis is
nowadays regarded as a crucial factor in wound healing [17, 46, 77, 113] and delayed or failed lymphatic re-
generation (such as that observed in diabetic patients) constitutes a major cause of impairment to wound
healing [3, 66,87].
Interest in lymphatics is therefore not just a mere scientific curiosity: their importance as pressure regulators
in tissues and, moreover, as vectors of the immune response has been emphasised in recent decades, particularly
in the context of wound healing [17, 43, 46]. The healing of a skin wound is a complex process consisting of
different overlapping phases that, if well orchestrated by the organism, lead to the restoration of the skin and
vasculature to a healthy, functional condition. Unfortunately, this delicate sequence of events can fail to proceed
to full healing in diabetic or aged patients [3,45,98]; indeed, if the organism response to infection is insufficient,
wound healing does not proceed through all normal stages, halting at the inflammation stage and resulting in
a chronic wound [10,79].
Non-healing wounds constitute a major health problem, seriously affecting the patient’s quality of life and
accounting for approximately 3% of all health care expenses in the UK [24,81]. Being the main mediators of the
immune response, lymphatics seem to significantly contribute to healing [77,113] and it has been observed that
failed lymphangiogenesis correlates with impaired wound healing [3,66,87]. However, little is known about the
actual mechanisms involved in the lymphangiogenic process, in contrast with the (blood) angiogenic case [5,18].
Mathematical modelling potentially provides an alternative, powerful tool to back up experimental observa-
tions, generate a better understanding of wound healing lymphangiogenesis and identify potential clinical tar-
gets. Here we build upon our ODE model presented in [7] to address the spatial elements of lymphangiogenesis,
specifically focussing on modelling two different hypotheses proposed to describe the exact lymphangiogenesis
mechanism.
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2 Biological background
2.1 Wound healing
For educational purposes, wound healing is usually presented as a sequence of four different (overlapping) phases,
namely:
1. Hemostasis: Shortly after injury, a blood clot is formed as a result of the interaction between blood and
the extracellular matrix; the clot stops the bleeding and provides a scaffold for cells and chemicals that
will consequently contribute to the healing process.
2. Inflammation: Substances activated during hemostasis attract leukocytes, inflammatory cells which clean
the wound from debris and pathogens and secrete chemicals which promote the evolution of the system
to the next phase.
3. Proliferation: The chemicals released during inflammation enhance the growth and aggregation of the sur-
rounding cells, restoring different tissue functions and elements such as the blood and lymphatic networks;
the regeneration of blood and lymphatic vessels is named (blood) angiogenesis and lymphangiogenesis, re-
spectively. In this phase, the blood clot is slowly substituted by a “temporary dermis” called granulation
tissue. In parallel with these processes, the rapid proliferation and migration of epidermal cells causes this
outer layer of the skin to re-form.
4. Remodelling : Finally, the granulation tissue is slowly replaced by normal skin tissue; this stage can take
up to two years to be completed.
For further details about wound healing we refer to [94] for normal cutaneous wound healing, and to [95] for an
account of chronic wound dynamics.
2.2 Sprouting versus self-organising lymphangiogenesis
The lymphatic system is a circulatory system responsible for mediating the immune response of the body and
maintaining the physiological pressure in tissues by draining excess liquid. It is mainly constituted of vessels
and lymph nodes. Lymphatic vessel walls are made of so-called lymphatic endothelial cells (LECs); contrary to
the blood case, lymphatic capillaries are very thin and are formed of a single layer of LECs.
To date, little is known about the biological events taking place during lymphangiogenesis and different
hypotheses have been proposed by biologists. Although important reviews on the subject such as [74,99] state
that lymphangiogenesis “occurs primarily by sprouting from pre-existing vessels”, in a fashion which resembles
the (blood) angiogenic case, recent experiments suggest that this may not be correct, at least not in some
specific experimental settings [5,85]. In [5] it is stated that lymphangiogenesis “can occur both by recruitment
of isolated lymphatic islands to a connected network and by filopodial sprouting”. Similarly, in [85] it is reported
that in an adult mouse tail wound model, LECs migrate as single cells into the wound space and later connect
to each other forming vessel structures (see Figure 1). According to the authors of [85], single LEC migration
following the lymph/interstitial flow would explain why lymphatic vessel regeneration appears to happen in this
direction (from left to right in the figure). Comparative reviews of lymphangiogenesis and (blood) angiogenesis
can be found in [1, 57,97].
2.3 Interstitial versus lymph flow
Interstitial flow is a fluid flow induced by dynamic stresses and pressure gradients through the extracellular
matrix. It is generally slower than fluid flow inside vessels, because of the resistance of the extracellular matrix
components; nonetheless, interstitial flow has recently been shown to play an important role in many processes,
including cell migration. Such effects can be purely mechanical, for example by “pushing” on the cell, or can
act indirectly by shifting the distribution of chemicals in the surroundings of the cell. A review of the effects of
interstitial flow on cell biology can be found in [86].
In recent years, a number of studies have investigated the role of interstitial flow on lymphangiogenesis,
mainly through the formation of concentration gradients of pro-lymphangiogenic factors. In particular, in [8]
the authors propose that interstitial flow, enhanced by the lymph flow resulting from interrupted lymphatic
vessels, can direct wound healing lymphangiogenesis by transporting LECs into the wound space and creating
gradients in chemicals (such as vascular endothelial growth factor – VEGF) which stimulate LEC growth and
chemotaxis. However, the relative role of interstitial and lymph flow on capillary regeneration has yet to be
investigated in depth; therefore, it is not clear which of the two takes on the greatest importance. In fact,
although interstitial flow is slower than the flux of the lymph coming from interrupted capillaries, the former
persists after wound closure, while the latter is more localised to open capillaries and stops once the lymphatic
network has been restored.
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Figure 1: In the photo, taken from [85, Figure 2], one observes blood and lymphatic vessel regeneration in
the tail of an adult mouse; lymphangiogenesis appears to occur in the direction of the interstitial flow. The
different photos refer to different times after wounding: A was taken at day 7, B at day 10, C at day 17 and
D at day 60. The yellow dashes mark the regenerating region (note its overall contraction over time); the red
colour indicates blood vessels, while LEC presence is highlighted by green colour. The open arrows signal how
blood vessels seem to sprout from deeper vessels, while other arrows point out LEC organisation at day 17 after
a higher LEC density is reached; arrowheads indicate single LECs migrating towards the proximal side of the
wound. Scale bar in D = 300 µm.
3 Mathematical Modelling
3.1 Review of lymphatic-related models
Contrary to the blood angiogenesis case, modelling literature about lymphangiogenesis is relatively immature
and sparse, and mostly refers to tumour-induced lymphangiogenesis (see for instance [32]). To the authors’
knowledge, the only models addressing lymphangiogenesis in wound healing are [84], which focuses on the
mechanical elements that lend the lymphatic network its characteristic shape (at least in the mouse tail), and
our previous work [7], which we are going to extend here. A recent review of mathematical models of vascular
network formation is [89], where indeed the imbalance between blood angio- and lymphangio-genesis modelling
is manifest.
A number of models have been produced by the bioengineering community, describing specific mechanical
features of lymphatic physiology; in particular, mechanics of contracting lymph valves have been presented
in [33, 41, 62, 68, 82]. A brief review of engineering models proposed in the lymphatic context can be found
in [65].
Very few attempts have been made to specifically model the effect of flow on capillary regeneration, although
one interesting example is [31], where the authors use a convection-diffusion model to analyse the effects of flow
on matrix-binding protein gradients.
3.2 Model targets
The model hereby presented aims to investigate the following questions about wound healing lymphangiogenesis:
• which hypothesis (self-organising or sprouting) offers a better explanation for the lymphangiogenesis me-
chanics?
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• what are the relative contributions of interstitial and lymph flow on the lymphangiogenic process?
• how does the initial wounded state impact on lymphatic regeneration?
3.3 Model variables and domain
In the following, we propose two similar but distinct PDE models to describe the two different theories advanced
by biologists to explain lymphangiogenesis in wound healing (see Section 2.2). We will refer to them as the
“self-organising” hypothesis (O) and the “sprouting” hypothesis (S).
For both cases, we consider the following basic dynamics: immediately after injury, transforming growth
factor-β (TGF-β) is activated and chemotactically attracts macrophages to the wound, which in turn secrete
VEGF which induces capillary regeneration acting on either LECs (in the self-organising case) or capillary
tips (in the sprouting case). The variables included in the models are summarised in Table 1, where they are
reported together with their names and units.
variable model quantity units
T (t, x) O,S active TGF-β concentration pg ·mm−3
M(t, x) O,S macrophage density cells ·mm−3
V (t, x) O,S VEGF concentration pg ·mm−3
L(t, x) O lymphatic endothelial cell density cells ·mm−3
E(t, x) S lymphatic capillary end (tip) density cells ·mm−3
C(t, x) O,S lymphatic capillary density cells ·mm−3
Table 1: A summary of the model variables.
We consider a 1D space variable x that varies between −ε and `+ ε; this interval includes the wound space
of length ` and a portion ε of healthy tissue on its edges. This kind of domain describes a narrow cut, where
at every point we average chemical and cell densities over the depth of the wound. We take the increasing-x
direction to be that of lymph flow (and interstitial flow). A schematic of the model domain is shown in Figure
2.
x−ε 0 ` (`+ ε)
skin
WOUND
skin
direction of the lymph flow
lymphatic
capillaries
Figure 2: The model 1D domain.
3.4 Advection velocity and open capillaries
The models incorporate an advection term for the majority of variables that accounts for the effect of flow on
the lymphatic regeneration process. In biological references (such as [8]) it is not clear whether flow is mainly a
result of lymph fluid exiting the interrupted capillaries, or the “normal” interstitial flow. We hence investigate
the relative contribution from these two components by considering an advection term motivated as follows.
In general, interstitial flow does not have a constant direction. However, for simplicity, here we will assume
that both lymph and interstitial flow occur in the increasing direction of x (from left to right in Figure 2);
this reflects what is observed in the wound healing experimental setting of [8], which we take as a reference for
model comparison. We assume the interstitial flow to be constant and present across the full tissue, reflecting
its persistent nature in healthy tissues. On the other hand, the contribution due to leaking lymphatic capillaries
is assumed to depend specifically on the density of open capillaries Cop and we assume a linear dependence for
simplicity. However, since we do not know the precise contribution of each element to the total advection, we
introduce a single “weight” parameter ξ, 0 ≤ ξ ≤ 1, which can be varied. Specifically, the advection velocities
for chemicals and cells, λchem and λcell respectively, will be taken to be of the forms
λchem(Cop) = ξ · (λchem1 · Cop) + (1− ξ) · λchem2 and (1)
λcell(Cop) = ξ · (λcell1 · Cop) + (1− ξ) · λcell2 , (2)
4
where 0 ≤ ξ ≤ 1 and λchem1 ,λchem2 ,λcell1 ,λcell2 are four parameters to be determined. In Appendix A.4 we estimate
the values of λchem1 and λ
chem
2 , while corresponding parameters for cells are assumed to be significantly smaller,
since advective cell velocity is likely to be smaller due to the higher environmental friction. A value of ξ = 0
corresponds to purely interstitial flow advection, while ξ = 1 represents advection due entirely to lymphatic
flow.
To quantify the open capillary density, we assume that as the “cut” in capillary density C becomes steeper
(and thus |∂C/∂x| → +∞), more capillaries are open and the open capillary density will increase towards its
maximum possible value of C, which would correspond to all capillaries being open. We therefore define the
open capillary density Cop as
Cop
(
C,
∂C
∂x
)
=
|∂C/∂x|
η0 + |∂C/∂x| · C (3)
where η0 is a parameter for whose estimation no relevant experimental data were found. See Figure 3 for a plot
of (3).
x0
C
Cop
x0
C
Cop
Figure 3: Plots of Cop (solid red) for different steepness of C (dashed blue).
3.5 Self-organising hypothesis
Under this hypothesis, single LECs migrate into the wound and start to self-organise into capillary structures
only after reaching a certain threshold density L∗. This case represents the direct extension of the ODE model
developed in [7] and the variable and parameter names have been kept as consistent with [7] as possible.
(Active) TGF-β equation
The differential equation describing active TGF-β concentration has the following form:
change in TGF-β
concentration
=
diffusion and
advection
+ activation − decay − internalisation by
macrophages.
Of these terms, the following three are assumed to have standard forms:
Diffusion: DT
∂2T
∂x2
, Decay: d1T , Internalisation: γ1TM ,
and advection will be taken to be −∂/∂x(λchem(Cop) · T ), with velocity λchem(Cop) as defined in (1).
Concerning the activation, we consider a constant amount of latent TGF-β in the skin TL [91, 100], which
is increased by macrophage production at rate r1 [50]. This latent form of TGF-β is activated by macrophages
[21, 36, 75, 100] and by the enzymes (mainly plasmin) present in the blood clot, which is mainly composed of
platelets [37, 44, 49] (for a review of TGF-β activation see [100]). Therefore, we take the following activation
term:
[amM + app(C)]︸ ︷︷ ︸
activation by macro-
-phages & plasmin
· [TL + r1M ]︸ ︷︷ ︸
latent TGF-β
.
The C-dependent quantity p is an estimate of plasmin presence in the wound, which is proportional to the
platelet mass. In fact, although activation of platelet-released TGF-β is still poorly understood, it seems that
plasmin, while degrading the blood clot, activates the latent TGF-β contained in the platelets [37]. We assume
that the plasmin level is proportional to the wound space which is not occupied by capillaries; this is motivated
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by the fact that capillary presence can be considered as a measure of the healing stage of the wound.1 When
capillary density gets close to its equilibrium (healthy state) value Ceq (say 90% of it), the plasmin-induced
TGF-β activation switches to zero. We will thus take
p(C) =
{ − ψ9/10·CeqC + ψ if C ≤ (Ceq · 9/10)
0 if C ≥ (Ceq · 9/10) . (4)
Macrophage equation
The following scheme will be considered for macrophage dynamics:
change in
macrophage
density
=
random movement
and advection
+
chemotaxis by
TGF-β
+
constant
source
+
influx from
open
capillaries
− removal and
differentiation
− crowding effect.
Macrophages are assumed to move randomly with diffusion coefficient µM , while their advection will be modelled
by the term − ∂∂x
(
λcell(Cop) ·M
)
, with λcell(Cop) as discussed in Section 3.4.
For the chemotaxis term, we first point out that only a fraction α of the monocytes that are chemoattracted
by TGF-β differentiate into (inflammatory) macrophages [63,107]. Therefore, the term describing macrophage
chemotaxis up TGF-β gradients will have the form
−αχ1 ∂
∂x
(
M
1 + ωM
·
∂T/∂x
1 + η1 |∂T/∂x|
)
where the macrophage velocity 11+ωM ·
∂T/∂x
1+η1|∂T/∂x| decreases as cell density increases (as in [103, 104]) and is
bounded as |∂T/∂x| → ∞. The presence of a constant source sM (from the bottom of the wound) is justified by
the observation that the macrophage equilibrium in unwounded skin is nonzero [110].
The introduction of an influx term is motivated by the fact that macrophages are “pumped out” from
interrupted capillaries [8, 85] and into the wound. We consider the following form for the influx term:
ϕ1
(
Cop,
∂C
∂x
)
= Cop · ζ1
(
∂C
∂x
)
, (5)
where Cop was introduced in (3) and ζ1 is defined as
ζ1
(
∂C
∂x
)
=
{
φ1 if ∂C/∂x < 0
0 otherwise .
(6)
In (6) φ1 is a parameter estimated in Appendix A.7. The Heaviside form of ζ1 is due to the influx only occurring
from the open lymphatic capillaries on the side of the wound from which lymph fluid flows (see Figure 2).
The removal term includes (inflammatory) macrophage death, differentiation into repair macrophages and
reintroduction into the vascular system, with the latter being proportional to the capillary density. Thus, we
take the removal term to be (d2 + ρC)M . We also include a crowding effect through the term −M+L+Ck1 ·M .
VEGF equation
For VEGF we assume the following dynamics:
change in
VEGF
concentration
=
diffusion and
advection
+ constant source +
production by
macrophages
− decay − internalisation by
LECs.
VEGF diffusion is modelled via the standard term DV
∂2V
∂x2 and advection by − ∂∂x
(
λchem(Cop) · V
)
where
λchem(Cop) is the expression defined in (1). The constant source is called sV , while the production term
will be r3M and the decay d3V . Internalisation is assumed to be linearly dependent on LEC density and the
corresponding term will consequently be γ2V L.
1An alternative approach would be to consider fibroblasts instead of capillaries here, but the introduction of a new variable and
consequently a new equation does not seem to be worthwhile, since capillary presence is a good indication of the healing state of
the wound.
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LEC equation
The equation describing the presence of LECs in the wound consists of the following terms:
change in
LEC density
=
random movement
and advection
+
chemotaxis by
VEGF
+
growth, upregulated by
VEGF and
downregulated by TGF-β
+
influx from open
capillaries
− crowding effect − transdifferentiation into
capillaries.
Again, random cell movement is modelled via a diffusion term µL∂
2L/∂x2 and the advection is taken to be
− ∂∂x
(
λcell(C) · L).
LECs are chemoattracted by VEGF [6, 99], and the chemotaxis term is assumed to be of a similar form to
that used to describe macrophage chemotaxis:
−χ2 ∂
∂x
(
L
1 + ωL
·
∂V/∂x
1 + η2 |∂V/∂x|
)
.
LEC growth is upregulated by VEGF [6,111,116] and downregulated by TGF-β [71, 96]:(
c1 +
V
c2 + c3V
)(
1
1 + c4T
)
L .
LECs are “pumped out” from the interrupted capillaries in a similar manner to macrophages, but also result
(with less intensity) from interrupted capillaries downstream of the lymph flow. The influx term this time takes
the form:
ϕ2
(
Cop,
∂C
∂x
)
= Cop · ζ2
(
∂C
∂x
)
(7)
where Cop is the density of open capillaries as in (3) and ζ2 is defined as
ζ2
(
∂C
∂x
)
=
{
φ+2 if ∂C/∂x < 0
φ−2 if ∂C/∂x > 0 ,
(8)
where φ+2 > φ
−
2 .
LECs cannot grow excessively due to crowding, which is taken into account via the term − (M+L+C)k2 · L.
When LECs have locally sufficiently populated the wound (i.e. when their density exceeds a threshold L∗ [8,85])
they are assumed to self-organise into capillaries at a rate which is increased by the presence of VEGF [80]:
σ(L,C) · (δ1 + δ2V )L
where
σ(L,C) =
{
1 if L+ C ≥ L∗
0 if L+ C < L∗ . (9)
Lymphatic capillary equation
After LECs have occupied enough of the wound space, they coalesce into a capillary network; also, they undergo
remodelling, which we model via a logistic term. Thus, the C-equation will be
σ(L,C) · (δ1 + δ2V )L︸ ︷︷ ︸
source
+ c5
(
1− C
k3
)
C︸ ︷︷ ︸
remodelling
.
Observe that no advection term is present here, since capillary structures are collections of cells attached to
each other and thus are more resistant to the interstitial flows.
Full system – “self-organising” hypothesis
The full system of equations in the “self-organising” hypothesis is therefore given by
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∂T
∂t
= DT
∂2T
∂x2
− ∂
∂x
(
λchem(Cop) · T
)
+ [amM + app(C)] · [TL + r1M ]
−d1T − γ1TM , (10)
∂M
∂t
= µM
∂2M
∂x2
− ∂
∂x
(
λcell(Cop) ·M + αχ1 M
1 + ωM
·
∂T/∂x
1 + η1 |∂T/∂x|
)
+sM + ϕ1
(
Cop,
∂C
∂x
)
− (d2 + ρC)M − M + L+ C
k1
M , (11)
∂V
∂t
= DV
∂2V
∂x2
− ∂
∂x
(
λchem(Cop) · V
)
+ sV + r3M − d3V − γ2V L , (12)
∂L
∂t
= µL
∂2L
∂x2
− ∂
∂x
(
λcell(Cop) · L+ χ2 L
1 + ωL
·
∂V/∂x
1 + η2 |∂V/∂x|
)
+
(
c1 +
V
c2 + c3V
)(
1
1 + c4T
)
L+ ϕ2
(
Cop,
∂C
∂x
)
−M + L+ C
k2
L− σ(L,C) · (δ1 + δ2V )L , (13)
∂C
∂t
= σ(L,C) · (δ1 + δ2V )L+ c5
(
1− C
k3
)
C , (14)
where λchem is defined in (1), λcell in (2), p in (4), ϕ1 in (5), ϕ2 in (7) and σ in (9). Parameters, initial and
boundary conditions are discussed in Sections 3.7 and 3.8 respectively. See Figure 4 for a summary of the fluxes
included in the model.
0 x
C
interstitial flow
macrophages
lymph lymph
LECs LECs
Figure 4: A summary of the fluxes included in the model: capillaries; fluid fluxes; macrophage influx;
LEC influx (only in O).
3.6 Sprouting hypothesis
Here, instead of LECs we consider capillary tip density E. Capillary tips are attached to the vessel ends and
therefore, contrary to LECs, are not subject to advection. As we will see, the introduction of this variable is
necessary in order to model directed capillary growth in response to a gradient. Examples of mathematical
models of blood angiogenesis (in wound healing and in tumours) which include the capillary tip variable can be
found in [12,13,29,30,55,64,88].
TGF-β, macrophage and VEGF equations are the same as in the self-organising case, except that in both
the crowding term for M and the V internalisation term there is E instead of L.
Lymphatic capillary ends (tips) equation
Capillary ends (or tips) are assumed to sprout from interrupted lymphatic capillaries, the density of which
(Cop) was defined in (3). Tip growth is enhanced by VEGF and inhibited by TGF-β and this is reflected by
the following term, similar to the one used for LECs in the self-organising case:(
c1 +
V
c2 + c3V
)(
1
1 + c4T
)
Cop .
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Importantly, capillary ends move in the direction of the (positive) gradient of VEGF with an upper-bounded
velocity, modelled by the term
−χ2 ∂
∂x
(
E ·
∂V/∂x
1 + η2 |∂V/∂x|
)
.
Finally, we assume that capillary tip death is due predominantly to overcrowding, and thus we include the
removal term − (M+E+C)k2 · E.
Lymphatic capillary equation
New capillaries are formed continuously from the interrupted ones in the direction defined by their tips. This
is modelled here according to the “snail trail” concept which was introduced in [25] for fungal colonies and
which has been widely used in models of (blood) angiogenesis [30]: newly formed capillaries are laid after the
sprouting tips, which therefore leave a sort of “track” behind.
Capillaries also undergo remodelling. Therefore, their dynamics are captured by the terms:
χ2
∣∣∣∣E · ∂V/∂x1 + η2 |∂V/∂x|
∣∣∣∣︸ ︷︷ ︸
sprouting
+ c5
(
1− C
k3
)
C︸ ︷︷ ︸
remodelling
.
Full system – “sprouting” hypothesis
Thus, the full system for the “sprouting” hypothesis is
∂T
∂t
= DT
∂2T
∂x2
− ∂
∂x
(
λchem(Cop) · T
)
+ [amM + app(C)] · [TL + r1M ]
−d1T − γ1TM , (15)
∂M
∂t
= µM
∂2M
∂x2
− ∂
∂x
(
λcell(Cop) ·M + αχ1 M
1 + ωM
·
∂T/∂x
1 + η1 |∂T/∂x|
)
+sM + ϕ1
(
Cop,
∂C
∂x
)
− (d2 + ρC)M − M + E + C
k1
M , (16)
∂V
∂t
= DV
∂2V
∂x2
− ∂
∂x
(
λchem(Cop) · V
)
+ sV + r3M − d3V − γ2V E , (17)
∂E
∂t
=
(
c1 +
V
c2 + c3V
)(
1
1 + c4T
)
Cop − χ2 ∂
∂x
(
E ·
∂V/∂x
1 + η2 |∂V/∂x|
)
−M + E + C
k2
E , (18)
∂C
∂t
= χ2
∣∣∣∣E · ∂V/∂x1 + η2 |∂V/∂x|
∣∣∣∣+ c5(1− Ck3
)
C , (19)
where λchem is defined in (1), λcell in (2), p in (4), ϕ1 in (5) and Cop in (3) (see Figure 4 for a summary of the
fluxes of the model).
3.7 Parameters
All the model parameters are reported in Table 2. Many of the parameters were estimated previously in [7] and
we refer to this source for details of their estimation. For the other parameters listed in Table 2, the details of
their estimation can be found in Appendix A.
3.8 Initial and boundary conditions
Initial Conditions
As initial time t = 0 we take the moment of wounding, when little chemical or cell populations are assumed
to have entered in the wound space. Specifically, we assume that at t = 0 there are no LECs (for model O) or
capillary tips (for S), while other variables can be present near the edges (recall our domain includes portions
of healthy skin surrounding the wound). We will then take the following initial conditions:
ν(0, x) = aν ·
[
1− tanh(bx) + tanh(b(−x+ `))
2
]
, (20)
L(0, x) = E(0, x) = 0 , (21)
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parameter value units source details
DT 2.76 mm
2day−1 [54, 72] Appendix A
η0 10
4 cells mm−4 no data found Appendix A
λchem1 1.35× 10−2 mmday−1 [27, 28] Appendix A
λchem2 8.64× 102 mmday−1 [86] Appendix A
ap 2.9× 10−2 mm3pg−1day−1 [21] [7]
ψ 105 pg mm−3 no data found Appendix A
am 0.45 mm
3cells−1day−1 [36, 75] [7]
TL 18 pg mm
−3 ( [76]) [7]
r1 3× 10−5 pg cells−1day−1 [50] [7]
d1 5× 102 day−1 [47] [7]
γ1 4.2× 10−3 mm3cells−1day−1 ( [115]) Appendix A
µM 0.12 mm
2day−1 [26] Appendix A
λcell1 1.35× 10−3 mmday−1 estimated ≈ 0.1× λchem1 Appendix A
λcell2 86.4 mmday
−1 estimated ≈ 0.1× λchem2 Appendix A
α 0.5 1 [109] [7]
χ1 4× 10−2 mm5pg−1day−1 [56] Appendix A
ω 1.67× 10−6 mm3cells−1 estimated ≈ 1/kold1 Appendix A
η1 100 mm
9pg−1 no data found Appendix A
sM 8.6× 102 cells mm−3day−1 ( [110]) Appendix A
φ1 2.05× 103 day−1 [14, 28] Appendix A
β 5× 10−3 1 [38] [7]
r2 1.22 day
−1 [118] [7]
d2 0.2 day
−1 [20] [7]
ρ 10−5 day−1cells−1 [85] [7]
k1 10
5 mm3cells−1 [118] Appendix A
DV 2.4 mm
2day−1 [69] Appendix A
sV 1.94 cells day
−1 ( [42,78]) [7]
r3 1.9× 10−3 pg cells−1day−1 ( [51,90]) [7]
d3 11 day
−1 [52] [7]
γ2 1.4× 10−3 mm3cells−1day−1 [61] [7]
µL 0.1 mm
2day−1 estimated ≈ µM Appendix A
c1 0.42 day
−1 [73] [7]
c2 42 day [111] [7]
c3 4.1 pg day mm
−3 [111] [7]
c4 0.24 mm
3pg−1 [71] [7]
χ2 0.173 mm
5pg−1day−1 [4] Appendix A
η2 1 mm
9pg−1 no data found Appendix A
φ+2 10
2 day−1 no data found Appendix A
φ−2 1 day
−1 estimated to be 1% of φ+2 Appendix A
k2 4.71× 105 cells day mm−3 [73] [7]
L∗ 104 cells mm−3 [85] [7]
δ1 5× 10−2 day−1 no data found [7]
δ2 10
−3 mm3pg−1day−1 no data found [7]
c5 0.42 day
−1 estimated = c1 Appendix A
k3 1.2× 104 mm3cells−1 estimated ≈ Ceq Appendix A
Table 2: A list of parameters appearing in the model equations; those referred to [7] for details are the
same as in the ODE model therein presented, while estimation of the newly introduced ones is discussed in
Appendix A. Each parameter is supplied with its estimated value, units and source used (when possible) to
assess it. References in brackets mean that although the parameter was not directly estimated from a dataset,
its calculated value was compared with the biological literature; the caption “no data found” signifies that no
suitable data were found to estimate the parameter. Note that am here corresponds to aM in [7] and γ2 here
to γ in [7]. kold1 denotes the parameter k1 in [7], where it is the macrophage carrying capacity. The parameter
d4 appears in the boundary conditions for L.
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where ν ∈ {T,M, V,C}. For each variable ν the value of aν is chosen to be such that ν(0,−ε) = ν(0, ` + ε) is
equal to the boundary conditions discussed in the following. Concerning b, we will vary its value to see how the
“sharpness” of the initial condition will affect lymphangiogenesis. For higher values of b, the initial conditions
become more step-like and we can interpret this as a deep wound with sharp edges: in this case, there would
be (almost) no capillaries in the centre of the wound. On the other hand, assigning smaller values of b would
correspond to a shallower initial wound, such that when averaging over the wound depth a certain number of
capillaries still remain. As an example, the plot of (20) for ν = T is shown in Figure 5 for different values of b.
x−ε `+ ε0 `
T eq
shallow wound
(e.g. b = 5)
x−ε `+ ε0 `
T eq
deep wound
(e.g. b = 100)
Figure 5: Initial condition T (0, x) = aT · {1− [tanh(b(x− ε))) + tanh(b(−x+ `− ε))]/2} for different values of
b. T eq denotes the T -equilibrium level in non-wounded skin.
Boundary Conditions
First of all, note that boundary conditions are not needed for C. We consider Dirichlet boundary conditions
for all other variables except L, for which we assume Robin boundary conditions. The choice of Dirichlet
boundary conditions is dictated by the fact that at the boundary the tissue is in a non-wounded state, and we
expect variables to remain close to their normal, equilibrium value there. For L, we apply instead the following
reasoning.
For LECs, we assume that once they pass the domain edge they move randomly and die at a constant rate
d4; in fact, it seems unrealistic to assume that they will just vanish once reaching the domain edge. Therefore
we will follow common practice for representation of habitat boundaries in ecological modelling [59]: we set a
different evolution equation for L inside and outside the domain. In the interior (i.e. for −ε < x < ` + ε), the
dynamics of L will be described by the equation (13); in the exterior (i.e. for x < −ε and x > `+ ε) instead we
assume that LECs move randomly and die (or transdifferentiate) with (high) constant rate d4. This gives the
equation
∂L
∂t
= µL
∂2L
∂x2
− d4L (22)
outside the wound, whose solution at equilibrium is given by
Lo(x) = Ao exp
(√
d4
µL
x
)
+Bo exp
(
−
√
d4
µL
x
)
(23)
where Ao and Bo are constants. Note that, since we want solutions to be bounded in order to be biologically
meaningful, we will take Bo = 0 for x < −ε and Ao = 0 for x > `+ ε. Since at the boundaries the outside and
the inside solutions should have the same value and the same flux, we have that
at x = −ε : L = Ao and ∂L
∂x
= Ao
√
d4
µL
⇒ ∂L
∂x
(t,−ε) =
√
d4
µL
L(t, 0)
at x = `+ ε : L = Bo exp
(
−
√
d4
µL
`
)
and
∂L
∂x
= −Bo
√
d4
µL
exp
(
−
√
d4
µL
`
)
⇒ ∂L
∂x
(t, `+ ε) = −
√
d4
µL
L(t, `)
which give the boundary conditions for L.
Summarising, the boundary conditions are
ν(t,−ε) = ν(t, `+ ε) = νeq , E(t,−ε) = E(t, `+ ε) = 0 , (24)
∂L
∂x
−
√
d4
µL
L = 0 at x = −ε , ∂L
∂x
+
√
d4
µL
L = 0 at x = `+ ε (25)
with ν ∈ {T,M, V,C} and where νeq denotes the equilibrium value in the unwounded skin for each variable.
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4 Numerical solutions
To simulate the two systems (10)-(14) and (15)-(19), a specific code was written which applies the Crank-
Nicolson method for the diffusion terms and a first-order upwind scheme for the chemotactic terms.
This section is structured as following: first, in 4.1, we present the data sets which will be used as reference
points in estimating the “goodness” of the simulations; then, in 4.2 we present a sample simulation of both the
whole O and S models; in 4.3 we explore how changes in b (initial condition steepness) and ξ (interstitial/lymph
flow balance) affect lymphatic regeneration; in 4.4 we address the two extreme cases where there is no advection
at all and where the two advection terms sum up (additive advection); finally, in 4.5 we summarise all the
observations concerning the different behaviour of O and S systems.
4.1 Data for comparison
We will compare our model simulations with experimental data reported in Figure 6. These experimental
observations show that the overall levels of LECs (both free and in a capillary structure) increase steadily after
wounding, and that while at day 10 the vast majority are in the distal half (i.e. upstream the lymph flow) by
60 days they are almost evenly distributed over the two sides.
Figure 6: Quantification of LEC presence and distribution in the regenerating region of a mouse tail wound.
Here the total numbers of LECs in the distal and proximal halves of the wound at different days post-wounding
are reported after data from (A) [85, Figure 2] and (B) [34, Figure 1].
Hence, from experimental data:
• lymphatics should have reached a density close to Ceq at day 60;
• LEC migration and/or lymphatic capillary formation should happen predominantly in the direction of the
lymph/interstitial flow.
4.2 A first simulation of O and S
We start by presenting simulations of the self-organising and sprouting cases (Figures 7 and 8, respectively)
with ξ = 0.5 (representing that interstitial and lymph flow are equally weighted in the overall advection term)
and a very smooth initial condition, with b = 5 (see (20)).
For these values of ξ and b, both systems predict lymphatic regeneration to be almost symmetric and a nearly-
complete network is restored by around day 60 (see Figures 7 and 8). Biologically, this represents the situation
in which a relatively shallow wound leaves more capillaries in the domain after wounding, so that regeneration
occurs mainly from remodelling of the pre-existing network. We note, however, that the distribution of the other
variables is highly asymmetric. This will lead to a non-symmetric lymphatic regeneration when parameters are
changed so that the chemical concentrations contribute more prominently to the lymphangiogenesis process.
One unexpected feature emerging from Figures 7 and 8 is that macrophage, VEGF and LEC levels are higher
than equilibrium in the healthy tissue on the right-hand-side of the wound, downstream the lymph flow. While
some overspill is likely to be observed, particularly macrophage density appears to be too high to be realistic.
In section 4.3 we will present results suggesting that the value ξ = 0.5 used in Figures 7 and 8 is inappropriately
low; the high downstream densities are a consequence of this. However an additional possible explanation
might be that more processes are involved in bringing cell and chemical levels back to normal in the healthy
skin surrounding a wound; macrophages are likely to be “re-absorbed” in the blood and lymphatic vasculature,
where their number is balanced by factors not included in the model. However, the simulations shown in Figures
7 and 8 do predict that eventually all the variables’ amounts go back to equilibrium as healing proceeds.
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Figure 7: Simulation of equations (10)–(14) (self-organising case) with parameters from Table 2 and initial
condition as defined in 3.8, with b = 5; ξ = 0.5. Arrows mark the direction of increasing t in the simulations.
Figure 8: Simulation of equations (15)–(19) (sprouting case) with parameters from Table 2 and initial condition
as defined in 3.8, with b = 5; ξ = 0.5. Arrows mark the direction of increasing t in the simulations.
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4.3 Varying b and ξ
“Visual” observations In order to clearly visualise the changes in dynamics when the parameters b and
ξ are varied, we report the approximate solution profiles of the lymphatic capillary density at different times
for different combinations of these two parameters; such simulations are reported in Tables 3 and 4 for the
self-organising and the sprouting case, respectively.
In the self-organising case, we observe that varying ξ between 0 and 0.75 does not significantly affect the
model output for capillary regeneration; on the other hand, the initial conditions play a crucial role, since for
a shallow wound (b = 5) the lymphatic network is almost completely restored by day 60, while almost no
healing is observed in the deep wound (b = 100) scenario. In addition, lymphangiogenesis happens in a fairly
symmetric fashion. However, things appear to be quite different for ξ = 1: in this case, both shallow and
deep wounds exhibit a left-to-right lymphangiogenic process, which is completed by day 60. Note that while
lymphangiogenesis occurs exclusively from left to right in the deep wound scenario, in the shallow wound some
lymphatic regeneration is also visible from the right-hand-side of the wound; this confirms our first observation
that in a shallow wound logistic remodelling plays a more prominent role than in the deep wound setting. These
results suggest that the self-organising hypothesis is supported by the assumption that lymph flow, rather than
interstitial flow, is the main contributor to advection in the wound space.
For the sprouting case, things are almost identical to the self-organising case for 0 ≤ ξ ≤ 0.75 and b = 5
(shallow wound scenario). However, varying ξ in this range seems to proportionally increase the left-to-right
regeneration speed in the deep wound case (b = 100), although it is still unable to account for complete
regeneration at day 60. In addition, for ξ = 1, while symmetric (although faster) healing is still visible for
b = 5, a capillary front advancing from right to left emerges in the deep wound scenario, though again this is
not fast enough to restore the network by day 60. This apparent “switch” of behaviour can be explained as
follows. ξ = 1 corresponds to an advection component due exclusively to lymph flow coming from interrupted
capillaries; hence, where Cop = 0 both cells and chemicals tend to accumulate on one side of the wound. In the
self-organising case, however, LECs display random movement and allow the capillary front to move. In the
sprouting scenario, on the other hand, capillary tips are not subject to either diffusion or advection; therefore,
the front of open capillaries tends to be stuck on the left-hand-side of the wound and chemotaxis tends to
happen from right to left. Thus, there is not such an obvious correlation between the value of ξ and the validity
of the sprouting hypothesis, in contrast to what we have seen above for the self-organising case. In the sprouting
case, a very precise balance of lymph and interstitial flow is required to give a left-to-right lymphangiogenesis
which is “fast enough”, that is one which completes by day 60.
To further investigate the “switch” of behaviour (from left-to-right to vice-versa) observed in Table 4 for
b = 100, we run some extra simulations of this case for 0.75 < ξ < 1. Results are reported in Figure 9 (note that
no significant difference is observed for 0.75 < ξ < 0.95, thus we report extra simulations only for values of ξ
starting from 0.95). The simulations in Figure 9 suggest that sprouting lymphangiogenesis switches from being
left-to-right to being right-to-left as ξ increases from 0 to 1, passing through symmetrical healing at around
ξ = 0.9775.
Therefore, the most “realistic” value for ξ seems to be ξO ≈ 1 for the self-organising case, and ξS ≈ 0.97
for the sprouting case. For these values, the self-organising case predicts total healing by day 60 (in accordance
with the data discussed in section 4.1), while the sprouting case is a bit delayed in this respect. However, all
the variables go back to their equilibrium levels in the latter case, while TGF-β, macrophages and VEGF stay
at a high concentration in the right-hand-side of the wound in the self-organising scenario, which is not what
we would expect to happen in reality (simulations not shown).
Quantitative observations In order to make these observations more quantitative and compare them di-
rectly with the data sets presented in section 4.1, in each case (i.e. both hypotheses and both combinations of
ξ and b values) we calculate a parameter pi60 to quantify the percentage of healing/lymphatic regeneration at
day 60. We also count how many LECs are present in the left (distal) and right (proximal) half of the domain
at days 10, 17, 25, 40 and 60; in this way, we can directly compare the model output with the empirical data
reported in Figure 6.
To define the quantity pi60, we consider one slice of the wound space, as depicted in Figure 2; we then
consider the ratio between the space occupied by the lymphatic capillaries at day 60 and the original wound
space. Thus, we consider
pi60 = 100 · SC,60 − SIC
Swound
, (26)
where SC,60 is calculated as the area under the C-curve at t = 60 (approximated as a polygon using the
numerical results shown above) and Swound = C
eq · (` + 2ε) − SIC ; SIC denotes the area subtended by the
capillary initial profile curve defined in (20), with ν = C. In this way, we estimate the portion of the real initial
wound (i.e. excluding the pre-existing capillary density) occupied by capillaries at day 60. The values of pi60
for the various cases considered above are reported in Table 5.
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ξ shallow wound (b = 5) deep wound (b = 100)
ξ
=
0
ξ
=
0.
7
5
ξ
=
1
Table 3: Plots of capillary density at different times for different values of b and ξ in the self-organising case
(equations (10)–(14)); arrows mark the direction of increasing t in the simulations. On the right-hand-side of
each box, we show bar plots of LEC presence (calculated as L+ C) in distal (D) and proximal (P) half of the
wound at days 10, 15, 25, 40 and 60 for different values of b and ξ.
ξ shallow wound (b = 5) deep wound (b = 100)
ξ
=
0
ξ
=
0.
7
5
ξ
=
1
Table 4: Plots of capillary density at different times for different values of b and ξ in the sprouting case
(equations (15)–(19)); arrows mark the direction of increasing t in the simulations. On the right-hand-side of
each box, we show bar plots of LEC presence (calculated as E + C) in distal (D) and proximal (P) half of the
wound at days 10, 15, 25, 40 and 60 for different values of b and ξ.
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Figure 9: Sprouting case: capillary density dynamics at different times for different values of ξ in the range 0.75
– 1 (ξ = 0.95, 0.97, 0.9775, 0.98, 0.9925, 0.995 – from left to right, top to bottom, respectively), with b = 100
(deep wound scenario). Arrows mark the direction of increasing t in the simulations.
shallow wound (b = 5)
ξ 0 0.25 0.5 0.75 1
O 97.2% 97.2% 97.2% 97.3% 101.7%
S 97.1% 97.1% 97.1% 97.1% 99.2%
deep wound (b = 100)
ξ 0 0.25 0.5 0.75 1
O 5.1% 5.1% 5.2% 5.2% 104.1%
S 6.6% 8.3% 10.5% 17.5% 10.6%
Table 5: Values of pi60 (defined in (26)) for different values of ξ and b in the self-organising (O) and sprouting
(S) cases.
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From Table 5, we can see clearly how at day 60 the lymphatic vasculature will be restored to a level of 97%
or more for any value of ξ in the shallow wound simulations in both the self-organising and sprouting case.
For a deeper wound, however, the lymphatic capillary population is restored only up to about 5% in the self-
organising case and up to about 17% in the sprouting case for ξ ≤ 0.75; also, while the parameter pi60 has more
or less the same value for all these ξ’s in the self-organising case, we observe an increase in pi60 for increasing
ξ in the sprouting scenario (from 6% to 17%). For ξ = 1, though, the healing predictions are quite different:
in the self-organising case, lymphatic capillary density slightly exceeds 100% healing, while the sprouting case
exhibits a capillary regeneration that covers only 10% of the original wound.
To compare the model predictions with the data reported in Figure 6, we plot the number of LECs (considered
as L+C and E+C in the self-organising and sprouting case respectively) in the left (distal) and right (proximal)
half of the domain at days 10, 17, 25, 40 and 60. Such numbers are reported as bars in Tables 3 and 4 (right-
hand-side of each box), which correspond exactly to the cases plotted in Tables 3 and 4 as simulations.
Comparing and contrasting the bar plots reported in Tables 3 and 4 (right-hand-side of each box) with the
data sets in Figure 6, we see that the row corresponding to ξ = 1 is by far the best match for the self-organising
case (the other values of ξ giving almost no difference between the distal and proximal LEC density in any day
after wounding). For the sprouting case, it is natural to make a different distinction: lymphatic regeneration
is always predicted to happen symmetrically in a shallow wound; in a deep wound, a slight distal-biased LEC
density is observed appearing at days 40 and 60 for ξ ≤ 0.75, while for ξ = 1 the LEC density in the proximal
half of the wound overtakes that in the distal half by day 60.
These observations confirm our first intuition: the self-organising case requires a value of ξ close to one in
order to observe a realistically fast left-to-right lymphangiogenesis, while the sprouting hypothesis needs a value
of ξ between 0.75 and 1 to produce similarly good results. This difference could be explained by the different
mechanisms regulating lymphangiogenesis in each case. In the self-organising hypothesis, capillaries form from
LEC self-aggregation and disposition in capillary structures once these are (locally) sufficiently abundant; a
constant ever-going interstitial flow slows this down because it prevents local LEC accumulation. In contrast
lymph flow occurs only nearby interrupted capillary fronts, which move on as LECs coalesce into vessels. In
the sprouting case, by contrast, the total absence of interstitial flow is a problem because neither capillary tips
nor well-formed capillaries are subject to either random movement or lymph flow from interrupted capillaries;
hence, interstitial flow is the only movement-inducing force, aside from chemical gradients. Moreover, in order
to observe a chemical concentration peak on the right-hand-side of the wound (which, by chemotaxis, would
induce a left-to-right migration of capillary tips), a good balance is required between an everywhere-present
interstitial flow and a locally-active lymph flow.
4.4 No advection and additive advection cases
We now consider two final cases: that of no advection at all and that with additive advection (that is, where
the advection velocity is as in (1) and (2), but without the coefficients involving the parameter ξ).
Simulations of the no advection case are shown in Table 6 for both the self-organising and sprouting models.
Note that, in the self-organising case, dynamics in the absence of advection resemble those reported in Table
3 for ξ = 1, although here capillary regeneration is a bit slower. Here the driving force behind left-to-right
lymphangiogenesis is the influx of macrophages (which produce VEGF) and LECs (which form capillaries) from
the left side of the interrupted capillaries. (Recall the influx term from the right edge is zero for macrophages
and very small for LECs.)
In the sprouting case, too, capillary density evolution reflects that previously observed for ξ = 1 (see Table 4).
However, contrary to the self-organising case, here dynamics are significantly faster in the absence of advection.
The reason behind this may lie in macrophages accumulating on the left side on the wound: consequently so
does VEGF, which then drives the capillary sprouting from the right towards the peak on the left. Observe
that here there are no LECs coming from the open capillaries on the left, so the regeneration is solely directed
by gradients (capillary tips move towards increasing gradients of VEGF).
These results suggest two conclusions regarding advection:
1. advection contributes to the speed of the lymphatic regeneration, speeding up the process in the self-
organising case and slowing it down under the sprouting hypothesis;
2. advection is of greater importance in the sprouting case, where it actually determines the direction (left-
to-right or vice versa) in which healing occurs.
In other words, while the self-organising hypothesis seems to be able to explain left-to-right lymphangiogenesis
on its own (thanks to the free LECs influx, primarily from the left side), the sprouting system needs some kind
of force pushing VEGF towards the right of the domain so as to form a gradient driving capillary sprouts from
the distal to the proximal end of the wound.
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shallow wound (b = 5) deep wound (b = 100)
O
S
Table 6: Simulation of the self-organising (O) and sprouting (S) systems with parameters from Table 2 and
initial condition as defined in 3.8 where the advection terms are switched to zero. Arrows mark the direction
of increasing t in the simulations.
Finally, we investigate what happens when the advection velocities for chemicals and cells are replaced,
respectively, by
λchem(Cop) = (λ
chem
1 · Cop) + λchem2 and (27)
λcell(Cop) = (λ
cell
1 · Cop) + λcell2 ; (28)
we call this the additive advection case. This time lymphangiogenesis, while not appearing overly affected in the
shallow wound case, is heavily slowed down in the deep wound scenario (simulation not shown). This reflects the
fact that, when lymphatic regeneration is driven mainly by chemical gradients, a sufficiently strong advection
force has a negative effect in healing because it does not allow chemicals and cells to accumulate and thereby
produce sufficiently steep gradients.
4.5 Overall comparison of O and S
Here the overall similarities and differences between the self-organising and sprouting hypotheses are sum-
marised:
• In shallow wounds lymphangiogenesis appears to be dominated by logistic growth/remodelling and occurs
symmetrically from both sides of the wound. In this case, there is little difference between the two
hypotheses in terms of the dynamics of wound healing lymphangiogenesis.
• Steeper initial conditions (as in a deep wound) lead to slower capillary regeneration; this is reasonable,
since smaller/shallower wounds are expected to heal faster [106,119] (see also [70] for burn depth). In the
deep wound case we also observe a marked difference in behaviour between the two hypotheses: the self-
organising case exhibits a very slow progression for values of ξ not close to 1, with the empirically observed
speed occurring for ξ = 1; by contrast, the sprouting hypothesis predicts lymphangiogenesis to take place
from left to right at a speed that increases with ξ up to ξ ≈ 0.9775, when it becomes symmetric; for
larger ξ healing switches to a right-to-left process, at decreasing speed as ξ approaches 1. This variety of
behaviour highlights how important the “balance” between interstitial and lymph flow is in the advection
terms (1) and (2).
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5 Discussion
The results presented in this paper provide new insights in the understanding of lymphangiogenesis mecha-
nisms. Wound healing lymphangiogenesis is increasingly considered a fundamental aspect of the regeneration
process, but there is still no consensus in the scientific community about how this phenomenon takes place.
In particular, two main hypotheses have been advanced to describe the lymphangiogenesis process: the self-
organising hypothesis [5,85] and the sprouting hypothesis [74,99]. Here we propose two different PDE systems
to describe the two sets of assumptions. The present work shows how the problem of determining the exact
lymphatic regeneration mechanism is intertwined with another open question in cellular biology: is interstitial
flow a determining factor in cell migration? [86] In this paper we explore the more general case of the effects
of advection due to the combination of interstitial flow and lymph flow coming from the interrupted capillaries.
In addition, we also consider how different initial conditions, corresponding to shallow and deep wounds, affect
the healing process.
The numerical simulations of the two systems we propose as describers for the self-organising and sprouting
hypotheses suggest that the observation of left-to-right lymphangiogenesis does not justify per se the self-
organising hypothesis: our sprouting-hypothesis system can also reproduce this phenomenon, although for a
very precise balance of lymph and interstitial flow. Therefore, a reliable value of ξ is needed in order to choose
between the two hypotheses. Other discriminating factors are that:
• capillary density in the sprouting case never significantly exceeds its normal value Ceq, while overcoming
this value is predicted in the self-organising case;
• in the self-organising case there is an excess of TGF-β, macrophages and VEGF persisting downstream
of the lymph flow after capillaries have reached their healthy equilibrium level.
Biologically, it is not clear which is the main contributor to advection between interstitial flow and lymph
flow coming from the interrupted capillaries; the models that we have presented suggest the latter is more
relevant, and that the value of ξ is above 0.75 in both modelled hypotheses. Moreover, our simulations hint at
an inhibiting action of interstitial flow on lymphangiogenesis: strong interstitial flow here seems to significantly
slow down capillary regeneration. This may be attributed to the fact that a ubiquitous advection force prevents
chemical gradients from forming on the “correct” side of the wound.
Finally, initial conditions (that is, the type of wound, shallow or deep) strongly affect the speed and shape
of the regeneration process: deeper wounds require more time to heal, and lymphangiogenesis will occur more
markedly in the direction of the lymph flow in this case.
Our results emphasise the importance of advection in tissue regeneration; this concept could be of particular
importance in describing the emerging concept of autologous chemotaxis, that is the phenomenon whereby a
cell can receive directional cues while at the same time being the source of such cues (see [86,92]).
Further developments of the model could include the blood vasculature, so to allow a direct comparison be-
tween the regenerations of the two vessel structures. The model could also be adapted to investigate differences
in lymphatic regeneration in a diabetic scenario, as in [7]. It would also be interesting to investigate the simi-
larities and the differences between wound healing lymphangiogenesis and tumour lymphangiogenesis: tumour
cells are known to release lymphangiogenic factors and the tumour mass alters tissue pressure and interstitial
flow, which could in turn promote pathological lymphangiogenesis in cancer [15,19,60,83,93].
A definitive answer to the question of whether the self-organising or sprouting hypothesis better describes
lymphangiogenesis will require a more informed evaluation of the relative contribution of interstitial and lymph
flow to advection in the wound space, and more detailed spatio-temporal measures of capillary density and
chemical concentrations: do we observe a “bump” exceeding normal capillary density along the capillary healing
front? Do TGF-β, macrophages and VEGF persist at a high level downstream of the lymph flow after lymphatic
regeneration is complete?
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A Parameter estimation
A.1 Sizes, weights, equilibria and velocities
A.1.1 Domain size
We consider a full-thickness wound of length ` = 5 mm, inspired by [117]. For the surrounding skin, we consider
a (small) variable width ε. Thus, we have a domain of length 5 mm + 2ε. In all the simulations reported in
the present paper, ε = 1; the nature of the observations does not change if a different value of ε is chosen
(simulations not shown).
A.1.2 TGF-β molecular weight and equilibrium T eq
We take TGF-β molecular weight to be approximately 25 kDa [9,108, active/mature isoform]. The equilibrium
value of active TGF-β is about 30 pg/mm3 [115, Figure 2].
A.1.3 Macrophage volume and equilibrium Meq
A human alveolar macrophage has a volume VMΦ of approximately 5000µm
3 = 5 × 10−6mm3 [53]. The
macrophage steady state can be estimated from [110, Figure 1], which plots typical macrophage density in the
skin. This shows that there is an average of about 15 macrophages per 0.1mm2 field. Assuming a visual depth
of 80 µm, the macrophage density becomes 15 cells/(0.1mm2 × 0.08mm) = 1875 cells/mm3.
A.1.4 VEGF molecular weight and equilibrium V eq
VEGF molecular weight is taken to be 38 kDa [48, 114, VEGF-165]. The VEGF equilibrium concentration is
estimated to be 0.5 pg/mm3 from [42, Figure 1] and [78, Figure 2].
A.1.5 Normal capillary density Ceq
In [85] we find that “it was not until day 60, when functional and continuous lymphatic capillaries appeared
normal” and “at day 60 the regenerated region had a complete lymphatic vasculature, the morphology of which
appeared similar to that of native vessels”. Hence, we assume that a capillary network that can be considered
“final” appears at day 60, and we take Ceq to be the number of LECs present at this time. In [85, Figure 2E]
we see that at that time there are about 80 cells. This value corresponds to a 12 µm thin section. In addition,
from [85, Figure 2D] we can calculate the observed wound area, which is about 5.6× 105 µm2. In this way we
get a volume of 0.0067 mm3 with 80 cells, which corresponds to Ceq = 1.2× 104 cells/mm3.
A.1.6 Maximum capillary density Cmax
First of all, we want to convert 1 capillary section into a cell number. For this purpose, we assume EC cross-
sectional dimensions to be those reported in [39], namely 10µm × 100µm. We then assume that LECs lie
“longitudinally” along the capillaries, and therefore only the short dimension contributes to cover or “wrap”
the circumference of the capillary. Considering a capillary diameter of 55 µm as in [28], we have that each
lymphatic capillary section is made of approximately 20 LECs (taking into account some overlapping). Then,
from [102] we know that EC thickness is approximately 0.5 µm. Thus a capillary section is a circle of about
55 + 2× 0.5µm diameter, corresponding, as described above, to 20 cells.
If we imagine stacking 1 mm3 with capillaries of this size, we see that we can pile on 1 mm/56µm ≈ 18
layers of capillaries. Then, considering an EC length of 100 µm as in [39], we have that 1 mm3 fits at most a
number of capillaries equivalent to the following amount of ECs:
20 cells × 18× 18× 1 mm
100µm
≈ 6.4× 104 cells = Cmax .
A.1.7 Lymph velocity
[28] suggests that the high lymph flow value (0.51mm/s) is due to high pressure following die injection. This
suggests that a lower value (9.7 microns/s) might be considered as typical, in agreement with [27]. In both
papers the normal lymph velocity seems to be around 10 microns/sec. We thus assume lymph velocity to be
vlymph = 10 micron/sec = 864 mm/day (from [27,28]).
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A.1.8 Interstitial flow velocity
First of all, we note that in [86] interstitial flow in the skin is calculated to be around 10 microns/sec. (Note
that [40] is relevant for this aspect of our modelling, although it is less important for the estimation of parameters;
in this reference the synergy between interstitial flow and VEGF gradient is discussed.) Therefore, we will
consider the interstitial flow to be also vIF = 10 microns/sec = 864 mm/day (from [86]).
A.2 Re-calculation of sM and k1
sM here is calculated in the same way as in [7], but using our amended model equations presented here. For k1, we
point out that in [7] this parameter was appearing in the logistic part of theM -equation: dM/dt = r2M−r2/k1·M2.
In the PDE systems we do not include such terms because only a minor fraction of macrophages undergo
mitosis [38]. However, death due to overcrowding is present in both models; comparing these terms, we see that
our “new” k1 corresponds to the “old” k1/r2.
A.3 Diffusion coefficients
A.3.1 VEGF diffusion coefficient DV
In [69] the authors observe that “in general, the diffusion coefficient of protein molecules in liquid is of the order
of 106 µm2/h = 24 mm2/day. This intuitively means that a molecule moves 10 µm/sec. To generate a gradient
over the order of 100 µm, the timescale of protein decay should be around 10 seconds. In this specific case the
protein decay time is about 1-10 hours. Therefore, the observed diffusion coefficient is too large and we need
some mechanism to slow down the diffusion” (where “this specific case” means that of VEGF).
In [69] the VEGF diffusion coefficient is estimated in three different ways: by a theoretical model (0.24 mm2/day),
and by two different empirical techniques (24 mm2/day). The authors then suggest a diffusion coefficient
of the order of 106 µm2/h = 24 mm2/day. However, they also used the same technique to determine the
diffusion coefficient at the cell surface; this time the diffusion coefficient is estimated to be approximately
104 µm2/h = 0.24 mm2/day. Keeping in mind all these considerations, for the model we take the intermediate
value DV = 2.4 mm
2/day.
A.3.2 TGF-β diffusion coefficient DT
In [54] the authors estimate a TGF-β diffusion coefficient of 0.36 mm2/h = 8.64 mm2/day from [11,35]. In [72]
the authors estimate a TGF-β diffusion coefficient of 2.54 mm2/day using the Stokes-Einstein Formula.
We checked their consistency with the estimate for DV above. The Stokes-Einstein equation of these cal-
culated values assumes spherical particles of radius r to have diffusion coefficient D ∼ 1/r; since the molecular
weight w of a particle is proportional to its volume, we have that D ∼ 1/ 3√w and thus DT ≈ 2.76.
A.3.3 Macrophage random motility µM
In [26] we find “Population random motility was characterized by the random motility coefficient, µ, which was
mathematically equivalent to a diffusion coefficient. µ varied little over a range of C5a [a protein] concentrations
with a minimum of 0.86× 10−8cm2/sec in 1× 10−7 M C5a to a maximum of 1.9× 10−8cm2/sec in 1× 10−11 M
C5a”. We thus take µM to be the average of these two values, that is µM = 1.38×10−8cm2/s ≈ 0.12 mm2/day.
A.4 Advection parameters λ1 and λ2
We will take λchem2 to be equal to vIF calculated in A.1; thus λ
chem
2 = 864 mm/day. For λ
chem
1 it is more
complicated, but we would say that if Cop reaches the maximum possible value Cmax calculated in A.1.6, then
λchem1 · Cop = vlymph, which was calculated in A.1. That is, we assume that if the skin is “packed” with open
capillaries, then the resulting flow will be the same as the usual lymph flow in the skin lymphatics). Hence
λchem1 = vlymph/Cmax = 0.0135 mm day
−1cell−1. For cells we assume smaller values due the higher friction
that cells encounter in the tissue. In the absence of relevant empirical data, we take λcell1 = 1/10 · λchem1 and
λcell2 = 1/10 · λchem2 .
A.5 Rate at which TGF-β is internalised by macrophages γ1
At equilibrium, C = Ceq and thus p(C) = 0. Therefore, the equation for T at equilibrium becomes
aMM
eq(TL + r1M
eq)− d1T eq − γ1T eqMeq = 0 ,
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which leads to
γ1 =
aMM
eq(TL + r1M
eq)− d1T eq
T eqMeq
≈ 0.0042 mm
3
cells · day .
A.6 Chemotaxis parameters
A.6.1 Macrophage chemotactic sensitivity towards TGF-β χ1
In [56, Table 1] the chemotaxis coefficients of neutrophils for different gradients of interleukin-8 are listed (ranging
from 0.6×10−7 to 12×10−7 mm2·mL·ng−1·s−1). We take the intermediate value χ1 = 5×10−7mm2mL ng−1s−1 ≈
4× 10−2mm2(pg/mm3)−1day−1. To compare this value with one from another source, we consider [101, Figure
8]: although the chemotaxis coefficient is shown to depend on the attractant concentration, an average value
is χ = 150 cm2sec−1M−1 ≈ 5.18 × 10−2mm2(pg/mm3)−1day−1 (using the TGF-β molecular weight found in
A.1.2). This result is encouraging because it is of the same order of magnitude as the previous estimate.
A.6.2 LEC chemotactic sensitivity towards VEGF χ2
In [4] a quantification is made of the effects of FGF2 and VEGF165 on HUVEC and HUAEC chemotaxis.
In [4, Figure 6A] it is reported that the total distance migrated per HUVEC in response to a 50 ng/mL gradient
of VEGFA165 was about 150 µm. Considering that the analysed area of the cell migration chamber was 800 µm
long and that the experiment lasted 200 minutes, we can estimate the endothelial cell velocity to be 150/200
= 0.75 µm/min = 1.08 mm/day and the VEGF gradient to be 50 ng/mL / 800 µm = 62.50 (pg/mm3)/mm.
Now, the flux J in our equation is given by J = χ2L∂V∂x ; however, J can also be seen as the product of the
mass density and the velocity of the flowing mass [23]. Therefore, with L being our mass density, we have
cell velocity = χ2
∂V
∂x
and then we can use the previous calculations to estimate
χ2 =
cell velocity
VEGF gradient
=
1.08mm/day
62.50(pg/mm
3
)/mm
= 0.0173
mm2
day
mm3
pg
.
In order to have realistic cell movement dynamics, χ2 is taken to be 10 times bigger. This can be justified by
the fact that the aforementioned data refer to HUVECs, and LECs might be faster than these cell types. A
more suitable dataset for this parameter would be very useful to better inform this estimate, but we are not
aware of such data. Also, chemical gradients created in vitro are usually different between those observed in
vivo and they are known to highly affect cell velocity.
A.6.3 Density-dependence of the macrophage chemotactic sensitivity ω
The cell density-dependence of the macrophage velocity is given by the factor 1/(1 + ωM). This velocity is
maximal when M is close to zero and we assume that it is halved when M reaches its carrying capacity kold1
(that is, the parameter k1 in [7]). We therefore take ω to be the inverse of the macrophage carrying capacity
kold1 .
A.7 Macrophage inflow φ1
We expect φ1 to be proportional to the lymph flow (estimated in A.1 as vlymph = 864 mm day
−1) and
macrophage presence in the lymph. In the same source [28] that we used to estimate vlymph, it is reported that
the mean capillary diameter is 55 µm. Thus about 2.05 mm3 of lymph pass through a capillary bi-dimensional
section in 1 day.
In [14] we find that a mouse leukocyte count in the blood is approximately 3 to 8 × 106 cells/mL, and
that of these about 2× 106 are macrophages coming from the lymph nodes; so we have a macrophage density
of 2 × 103 cells/mm3 in the lymph. Therefore, each day about 2.05 mm3 × 2 × 103 cells/mm3 = 4.11 × 103
macrophages pass in one capillary. Converting capillaries into cell density as was done in A.1.6, we have an
influx equal to 4.1120 × 103day−1 = 0.205× 103day−1. However, the macrophage density reported in [14] refers to
blood; we assume that this quantity in lymph (especially during inflammation) will be about 10 times bigger.
Therefore, we will take φ1 = 2.05× 103day−1.
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